SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-006317
Filing Date
2022-03-16
Accepted
2022-03-16 07:58:12
Documents
16
Period of Report
2022-03-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tvst-20220315.htm   iXBRL 8-K 46037
2 EX-10.1 exhibit101-8xk.htm EX-10.1 258400
3 EX-10.2 exhibit102-8xk.htm EX-10.2 113424
4 EX-99.1 exhibit991-8xk.htm EX-99.1 17369
8 a2seventylogo.jpg GRAPHIC 31837
  Complete submission text file 0001628280-22-006317.txt   706275

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvst-20220315.xsd EX-101.SCH 2008
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvst-20220315_lab.xml EX-101.LAB 24831
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvst-20220315_pre.xml EX-101.PRE 13142
10 EXTRACTED XBRL INSTANCE DOCUMENT tvst-20220315_htm.xml XML 11503
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 22743324
SIC: 2834 Pharmaceutical Preparations